Biomerica Inc. (NASDAQ:BMRA) finished Tuesday with an addition of $0.3 to close at $5.93, an upside of 5.33 percent. An average of 22,841,461 shares of common stock have been traded in the last five days. There was a gain of $1.14 in the past week. The last 20 days have seen an average of 5,754,785 shares traded, while the 50-day average volume stands at 2,365,124.
BMRA stock has increased by 25.64% in the last month. The company shares reached their 1-month lowest point of $4.05 on 09/14/21. With the stock rallying to its 52-week high on 02/11/21, shares of the company touched a low of $3.30 and a high of $8.15 in 52 weeks. In spite of this, the price is down -27.24% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Biomerica Inc. (BMRA) has a trailing price-to-earnings (P/E) ratio of 26.50 for the broader industry and 31.87 for the sector. This means investors are optimistic about the stock’s future prospects. The stock’s beta is -0.67. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 7.47, the price-to-book (PB) ratio at 7.91.
The quick ratio of Biomerica Inc. for the three months ended May 30 was 4.60, and the current ratio was 7.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending May 30. On the profitability front, the trailing 12-month gross margin is 6.90% against a 5-year average of 25.0%. Biomerica Inc.’s EBITDA margin for the year ending May 30 is -85.38%, while its operating margin for the same period stands at -90.60%. Its gross profit as reported stood at $0.5 million compared to revenue of $7.2 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Biomerica Inc.’s return on assets was -46.60%, compared to -31.3% over the last five years. In the past year, the return on investment has been -71.00%, and the 5-year average is -36.5%. Meanwhile, the return on equity (ROE) for the past 12 months has been -59.50% and the 5-year average holds at -38.1%. For the broader industry, ROE averaged -2.89 over the past year.
From a technical analysis perspective, let’s take a brief look at Biomerica Inc. (BMRA) price momentum. RSI 9-day as of the close on 05 October was 66.44%, suggesting the stock is Neutral, with historical volatility in this time frame at 184.85%.
As of today, BMRA’s price is $5.39 +23.80% or $1.14 from its 5-day moving average. BMRA is currently trading +35.08% higher than its 20-day SMA and +64.72% higher than its 100-day SMA. However, the stock’s current price level is +64.27% above the SMA50 and +6.08% above the SMA200.
The stochastic %K and %D were 67.48% and 60.80%, respectively, and the average true range (ATR) was 0.73. With the 14-day stochastic at 55.93% and the average true range at 0.58, the RSI (14) stands at 65.22%. The stock has reached 0.76 on the 9-day MACD Oscillator while the 14-day reading was at 1.01.
Colliers Securities launched coverage on Biomerica Inc. (NASDAQ: BMRA) in its analyst report released on November 10, 2020. The firm assigned the stock a a Buy rating.The consensus rating for Biomerica Inc. (BMRA) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell BMRA, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is BMRA’s price target for the next 12 months?
Analysts predict a range of price targets between $13.00 and $13.00, with a median target of $13.00. Taking a look at these predictions, the average price target given by analysts for Biomerica Inc. (BMRA) stock is $13.00.